Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | 18,134 | reported | 18 May 2026 | tx 12+78,027−925 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 14,227 | 0.00 USD | |
| 14 May 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 1.92 USD | |
| 01 Mar 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 31,900 | 0.00 USD | deriv |
| 14 Feb 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 116 | 1.63 USD | |
| 14 Nov 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 2.24 USD | |
| 14 Aug 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 1.39 USD | |
| 14 May 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 1.14 USD | |
| 01 Mar 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 31,900 | 0.00 USD | deriv |
| 14 Feb 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 116 | 5.42 USD | |
| 14 Nov 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 7.92 USD | |
| 14 Aug 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 7.02 USD | |
| 14 May 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 99 | 8.36 USD |